Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics

Methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics

US Patent 12012461 · Granted Jun 18, 2024

Estimated economic value: $201,197,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GPRC5D chimeric antigen receptors and cells expressing the same2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Methods for treating multiple myeloma2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2023
Anti-CD3 antibodies and uses thereof2023
Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof2022
Immune modulation and treatment of solid tumors with antibodies that specificall2021